Thank you.
In fact, what I tried to explain at the beginning is that the $18 billion target represents an increase of 30%, roughly, compared with the sixth replenishment. That 30% is not because we have suddenly become more expensive. In fact, we have very low operating costs. For your information, 5.2% is our level of operating costs; so it's very, very low. The increased target is because of the COVID-19 knock-on impact on these three diseases. This 30% increase is what our funding needs are. This is what we expect our major donors to consider as a potential pledge this time.
As I said, what is happening is that the U.S., as the host, but also as our largest donor, has already committed that 30% increase, with a commitment of $6 billion. If we want to unlock the $6 billion from the U.S., we need to find the other $12 billion. This is why it's so important that all of our major donors step up. If they don't, we won't be able to find the $12 billion and therefore will leave the U.S. money unavailable on the table.